Abstract:Mycobacterium tuberculosis (M. tuberculosis) remains a significant global health threat, accounting for ~1.7 million deaths annually. The efficacy of the current vaccine, M. bovis BCG, ranges from 0 to 80% in children and does not prevent adulthood tuberculosis. We explored the immune profile and safety of a live-attenuated M. tuberculosis construct with double deletions of the mosR and echA7 genes, where previously, single mutations were protective against an M. tuberculosis aerosol challenge. Over 32 weeks post-vaccination (WPV), immunized mice with M. tuberculosisΔmosRΔechA7 (double mutant) were sacrificed to evaluate the vaccine persistence, histopathology, and immune responses. Interestingly, despite similar tissue colonization between the vaccine double mutant and wild-type M. tuberculosis, the vaccine construct showed a greater reaction to the ESAT-6, TB.10, and Ag85B antigens with peptide stimulation. Additionally, there was a greater number of antigen-specific CD4 T cells in the vaccine group, accompanied by significant polyfunctional T-cell responses not observed in the other groups. Histologically, mild but widely distributed inflammatory responses were recorded in the livers and lungs of the immunized animals at early timepoints, which turned into organized inflammatory foci via 32WPV, a pathology not observed in BCG-immunized mice. A lower double-mutant dose resulted in significantly less tissue colonization and less tissue inflammation. Overall, the double-mutant vaccine elicited robust immune responses dominated by antigen-specific CD4 T cells, but also triggered tissue damage and vaccine persistence. The findings highlight key features associated with the immunogenicity and safety of the examined vaccine construct that can benefit the future evaluation of other live vaccines.

Anti-mycobacterial immunity induced by a single injection of M. leprae Hsp65-encoding plasmid DNA in biodegradable microparticles.

Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.

A Single Mycobacterial Protein (hsp 65) Expressed by a Transgenic Antigen-Presenting Cell Vaccinates Mice Against Tuberculosis.

A Heterologous DNA Priming-Mycobacterium Bovis BCG Boosting Immunization Strategy Using Mycobacterial Hsp70, Hsp65, and Apa Antigens Improves Protection Against Tuberculosis in Mice.

Induction of strong immune response against a multicomponent antigen of Mycobacterium tuberculosis in BALB/c mice using PLGA and DOTAP adjuvant

Towards A Dna Vaccine Against Tuberculosis

Protection Against Tuberculosis By Plasmid Dna

Protection Against Tuberculosis by Bone Marrow Cells Expressing Mycobacterial Hsp65.

Vaccination Against Tuberculosis by DNA Injection

Combined DNA Vaccine Encapsulated in Microspheres Enhanced Protection Efficacy Against Mycobacterium Tuberculosis Infection of Mice

Improved Immunogenicity of DNA Vaccination with Mycobacterial HSP65 Against Bovine Tuberculosis by Protein Boosting

Protection Against Tuberculosis by Passive Transfer with T-cell Clones Recognizing Mycobacterial Heat-Shock Protein 65.

The Immunogenicity and Safety of Mycobacterium tuberculosis-mosR-Based Double Deletion Strain in Mice

Vaccination with Mincle agonist UM-1098 and mycobacterial antigens induces protective Th1 and Th17 responses

Protection of Rats from Adjuvant Arthritis by Immunization with Naked Dna Encoding for Mycobacterial Heat Shock Protein 65

Enhanced Protective Efficacy Against Mycobacterium Tuberculosis Afforded by BCG Prime‐dna Boost Regimen in an Early Challenge Mouse Model is Associated with Increased Splenic Interleukin‐2‐producing CD4 T‐cell Frequency Post‐vaccination

Safety and Immunogenicity of an In Vivo Muscle Electroporation Delivery System for DNA- hsp65 Tuberculosis Vaccine in Cynomolgus Monkeys

Expression and Purification of Heat Shock Protein 65(HSP65) of Mycobacterium Leprae and Preparation of Anti-HSP65 Polyclonal Antiserum

Vaccination Of Mice And Cattle With Plasmid Dna Encoding The Mycobacterium Bovis Antigen Mpb83

RNA Encoding the MPT83 Antigen Induces Protective Immune Responses Againstmycobacterium Tuberculosisinfection

HSP65 Vaccine Significantly Enhanced Systemic and Pulmonary Tuberculosis-Specific IFN-gamma Responses